Daniel L Suzman

Daniel L Suzman

UNVERIFIED PROFILE

Are you Daniel L Suzman?   Register this Author

Register author
Daniel L Suzman

Daniel L Suzman

Publications by authors named "Daniel L Suzman"

Are you Daniel L Suzman?   Register this Author

22Publications

367Reads

39Profile Views

Exploration of baseline patient-reported side effect bother from cancer therapy.

Clin Trials 2020 Mar 10:1740774520910389. Epub 2020 Mar 10.

Oncology Center of Excellence, Food and Drug Administration (US FDA), Silver Spring, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774520910389DOI Listing
March 2020

Global Variation in Opioid Use in Prostate Cancer Trials.

JAMA Oncol 2019 Sep 12:e192971. Epub 2019 Sep 12.

Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.2971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743059PMC
September 2019

Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents.

Liver Int 2018 06 24;38(6):976-987. Epub 2018 Apr 24.

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13746DOI Listing
June 2018

Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1-defined disease progression in clinical trials.

Semin Oncol 2017 Feb 10;44(1):3-7. Epub 2017 Feb 10.

Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2017.01.001DOI Listing
February 2017

FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy.

Oncologist 2016 05 16;21(5):634-42. Epub 2016 Mar 16.

Office of Hematology and Oncology Products and Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861371PMC
May 2016

Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.

Prostate 2015 Nov 26;75(15):1814-20. Epub 2015 Aug 26.

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23064DOI Listing
November 2015

Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer.

Cancers (Basel) 2015 Sep 29;7(4):1983-93. Epub 2015 Sep 29.

Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, CRB1-1M45, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers7040871DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695871PMC
September 2015

Does degree of androgen suppression matter in hormone-sensitive prostate cancer?

J Clin Oncol 2015 Apr 2;33(10):1098-100. Epub 2015 Mar 2.

Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.1419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886659PMC
April 2015

Bone-targeting agents in prostate cancer.

Cancer Metastasis Rev 2014 Sep;33(2-3):619-28

Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB1-1 M45, Baltimore, MD, 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-013-9480-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087085PMC
September 2014

Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.

Prostate 2014 Sep 22;74(13):1278-85. Epub 2014 Jul 22.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144818PMC
September 2014

Castration-resistant prostate cancer: latest evidence and therapeutic implications.

Ther Adv Med Oncol 2014 Jul;6(4):167-79

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, CRB1-1M45, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834014529176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107711PMC
July 2014

Determining the optimal treatment for metastatic castration-resistant prostate cancer: age should not be a factor.

Eur Urol 2014 May 16;65(5):884-6. Epub 2013 Oct 16.

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838130107
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2013.10.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090698PMC
May 2014

High-dose itraconazole as a noncastrating therapy for a patient with biochemically recurrent prostate cancer.

Clin Genitourin Cancer 2014 Apr 14;12(2):e51-3. Epub 2013 Nov 14.

Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore MD. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673130028
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2013.11.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959234PMC
April 2014

Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin.

AIDS 2004 Sep;18(13):1805-9

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200409030-00009DOI Listing
September 2004

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.

AIDS 2003 May;17(8):1167-72

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200305230-00008DOI Listing
May 2003

Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis.

Clin Infect Dis 2003 Apr 3;36(8):1063-6. Epub 2003 Apr 3.

National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/374050DOI Listing
April 2003